Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aeee8d3f65d495ab7c77f7132d3b5da2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a8a4e2f7c5c4847a0645b0c8a98204a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ac668aff7ed0fd8b74fd7a8127131bf |
publicationDate |
2012-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2828616-A1 |
titleOfInvention |
Uses of modified elr-cxc chemokine g31p to treat cancer |
abstract |
Described herein is the use of a modified human chemokine, GS-CXCL8(3- 72)K11 R/G31 P or G31 P in the treatment of a number of cancers, including but by no means limited to prostate cancer, liver cancer and melanoma. |
priorityDate |
2011-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |